OpenVSafe by OpenVAERS
Search V-safe

DLN-25684-76906

1 vaccination 1 coded response 9 check-ins 1 free-text entry 0 call cases
Sex
Female
Age at first dose
26-30
ZIP prefix
977 / OR
Registered
2021-04-05
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-05
    Registered in v-safe
  2. 2021-04-05
    Dose 1 — Janssen/Johnson & Johnson
  3. 2021-04-05
    Health check-in — day 0, dose 1
    Feeling: Good · Site: Pain · None
    Adult check-in
  4. 2021-04-06
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  5. 2021-04-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  6. 2021-04-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Site: Pain · Fatigue or tiredness
    Adult check-in
  7. 2021-04-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-04-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  9. 2021-04-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Erythema, Pruritus — Feeling: Good
    Free text: Mild redness/itching on both arms through the night last night (new symptom, could potentially be unrelated but not sure what else it could be)
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-19
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  11. 2021-04-28
    Health check-in — day 21, single dose
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-04-05Janssen/Johnson & Johnson

Free text

Release 7 — days 1–6 daily, dose 1

2021-04-11

Systemic reaction (other): Mild redness/itching on both arms through the night last night (new symptom, could potentially be unrelated but not sure what else it could be)

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SROErythema ✓ ✓ ✓
SROPruritus ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release